Claes G. Tropé

11.7k total citations · 1 hit paper
216 papers, 8.6k citations indexed

About

Claes G. Tropé is a scholar working on Reproductive Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Claes G. Tropé has authored 216 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Reproductive Medicine, 78 papers in Molecular Biology and 60 papers in Oncology. Recurrent topics in Claes G. Tropé's work include Ovarian cancer diagnosis and treatment (101 papers), Endometrial and Cervical Cancer Treatments (34 papers) and Intraperitoneal and Appendiceal Malignancies (20 papers). Claes G. Tropé is often cited by papers focused on Ovarian cancer diagnosis and treatment (101 papers), Endometrial and Cervical Cancer Treatments (34 papers) and Intraperitoneal and Appendiceal Malignancies (20 papers). Claes G. Tropé collaborates with scholars based in Norway, United States and Israel. Claes G. Tropé's co-authors include Ben Davidson, Gunnar B. Kristensen, J. Kærn, Reuven Reich, Ignace Vergote, Vera M. Abeler, Ruth Holm, Bjørn Risberg, Jahn M. Nesland and Antonio Casado and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Claes G. Tropé

216 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

2010 1.7k citations Ignace Vergote, Claes G. Tropé et al. profile →

Peers

Countries citing papers authored by Claes G. Tropé

Since Specialization

Citations

This map shows the geographic impact of Claes G. Tropé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claes G. Tropé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claes G. Tropé more than expected).

Fields of papers citing papers by Claes G. Tropé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claes G. Tropé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claes G. Tropé. The network helps show where Claes G. Tropé may publish in the future.

Co-authorship network of co-authors of Claes G. Tropé

This figure shows the co-authorship network connecting the top 25 collaborators of Claes G. Tropé. A scholar is included among the top collaborators of Claes G. Tropé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claes G. Tropé. Claes G. Tropé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Survival after secondary cytoreductive surgery and chemotherapy compared with chemotherapy alone for first recurrence in patients with platinum‐sensitive epithelial ovarian cancer and no residuals after primary treatment. A registry‐based study 2018 ·Acta Obstetricia Et Gynecologica Scandinavica ·(unknown), Hilde Langseth, Tor Åge Myklebust, J. Kærn, Claes G. Tropé, Torbjørn Paulsen	6
2	Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas 2018 ·International Journal of Cancer ·Antonio Agostini, Marta Brunetti, Ben Davidson, Claes G. Tropé, Sverre Heim, Ioannis Panagopoulos, Francesca Micci	9
3	The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective study 2015 ·BMC Cancer ·Ruixia Huang, Xiaoran Li, Ruth Holm, Claes G. Tropé, Jahn M. Nesland, Zhenhe Suo	28
4	HMGA2 expression pattern and TERT mutations in tumors of the vulva 2015 ·Oncology Reports ·Antonio Agostini, Ioannis Panagopoulos, (unknown), (unknown), Ben Davidson, Claes G. Tropé, Sverre Heim, Francesca Micci	17
5	Sex Hormone-Binding Globulin (SHBG) Expression in Ovarian Carcinomas and Its Clinicopathological Associations 2013 ·PLoS ONE ·Ruixia Huang, Yuanyuan Ma, Ruth Holm, Claes G. Tropé, Jahn M. Nesland, Zhenhe Suo	15
6	Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases 2013 ·Human Pathology ·Olga Vaksman, Ben Davidson, Claes G. Tropé, Reuven Reich	28
7	Migfilin, α-parvin and β-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases 2012 ·Gynecologic Oncology ·Ben Davidson, Arild Holth, Mai T. Nguyen, Claes G. Tropé, Chuanyue Wu	6
8	Flow cytometric measurement of cellular FLICE‐inhibitory protein (c‐FLIP) in ovarian carcinoma effusions 2011 ·Cytopathology ·Hiep Phuc Dong, Anne Katrine Ree Rosnes, (unknown), (unknown), Viví Ann Flørenes, Claes G. Tropé, Bjørn Risberg, Ben Davidson	2
9	DNA Ploidy Heterogeneity in Endometrial Carcinoma 2010 ·International Journal of Gynecological Pathology ·Manohar Pradhan, Vera M. Abeler, Ben Davidson, Wanja Kildal, (unknown), Claes G. Tropé, Bjørn Risberg, Håvard E. Danielsen	9
10	Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin 2010 ·American Journal Of Pathology ·Joon Tae Park, Xu Chen, Claes G. Tropé, Ben Davidson, Ie‐Ming Shih, Tian‐Li Wang	149
11	Expression and Clinical Role of Antiapoptotic Proteins of the Bag, Heat Shock, and Bcl-2 Families in Effusions, Primary Tumors, and Solid Metastases in Ovarian Carcinoma 2009 ·International Journal of Gynecological Pathology ·Mari Bunkholt Elstrand, Lilach Kleinberg, Elise C. Kohn, Claes G. Tropé, Ben Davidson	33
12	Gross genomic alterations differ between serous borderline tumors and serous adenocarcinomas—an image cytometric DNA ploidy analysis of 307 cases with histogenetic implications 2009 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Manohar Pradhan, Ben Davidson, Claes G. Tropé, Håvard E. Danielsen, Vera M. Abeler, Bjørn Risberg	8
13	Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: A controlled observational study 2008 ·European Journal of Cancer ·Trond Melbye Michelsen, Are Hugo Pripp, Serena Tonstad, Claes G. Tropé, Anne Dørum	53
14	Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer 2007 ·Cancer ·Christian Marth, Joan L. Walker, Richard R. Barakat, Antonio Casado, Angiolo Gadducci, Brigitte Miller, Franco Odicino, Eric Pujade‐Lauraine, Jalid Sehouli, Claes G. Tropé, Lari Wenzel, Alain G. Zeimet	23
15	Proteomic Analysis of Malignant Ovarian Cancer Effusions as a Tool for Biologic and Prognostic Profiling 2006 ·Clinical Cancer Research ·Ben Davidson, Virginia Espina, Seth M. Steinberg, Viví Ann Flørenes, Lance A. Liotta, Gunnar B. Kristensen, Claes G. Tropé, Aasmund Berner, Elise C. Kohn	62
16	Genome profiles of bilateral dysgerminomas, a unilateral gonadoblastoma, and a metastasis from a 46, XY phenotypic female 2003 ·Human Pathology ·Wanja Kildal, Sigrid Marie Kraggerud, Vera M. Abeler, Sverre Heim, Claes G. Tropé, Gunnar B. Kristensen, Bjørn Risberg, Ragnhild A. Lothe, Håvard E. Danielsen	14
17	Long-term results from a phase II study of paclitaxel combined with doxorubicin in recurrent platinum refractory ovarian cancer. 2001 ·PubMed ·Claes G. Tropé, (unknown), (unknown), J. Kærn	2
18	Ten-year results of a randomised trial comparing cisplatin with cisplatin and cyclophosphamide in advanced, suboptimally debulked ovarian cancer 1998 ·European Journal of Cancer ·Christian Marth, Claes G. Tropé, (unknown), Gunnar B. Kristensen	10
19	Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse 1993 ·American Journal of Obstetrics and Gynecology ·Ignace Vergote, J. Kærn, Vera M. Abeler, Erik O. Pettersen, (unknown), Claes G. Tropé	93
20	Epidemiology, etiology, screening, prevention, and diagnosis in female genital cancer 1991 ·Current Opinion in Oncology ·Claes G. Tropé, Amin Makar	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact